Tag: cephalosporin market outlook

  • Evaluating the Cephalosporin  Market’s Growth Prospects from 2024 to 2033

    Evaluating the Cephalosporin Market’s Growth Prospects from 2024 to 2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Cephalosporin Market from 2024 to 2033?

    The cephalosporin market has grown steadily, with an expected increase from $17.04 billion in 2023 to $17.69 billion in 2024, at a CAGR of 3.8%. Key factors supporting this growth include the rising prevalence of bacterial infections, antibiotic resistance, expanding surgical and hospitalization rates, greater awareness among healthcare professionals, and supportive regulations for antibiotic development.

    The cephalosporin market is projected to grow steadily, reaching $20.29 billion by 2028, with a CAGR of 3.5%. Factors contributing to growth include the increasing global burden of infectious diseases, the rise in bacterial resistance, growth in surgical procedures, healthcare-associated infections, rising demand for broad-spectrum antibiotics, and evolving reimbursement policies. Key trends in the forecast period include technological advancements, regulatory changes, market expansion with advanced solutions, and collaborations and partnerships.

    Claim Your Free Sample of the Global Cephalosporin Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13402&type=smp

    What Key Factors Are Fueling the Growth of the Cephalosporin Market?

    The growing prevalence of infectious diseases is anticipated to drive the growth of the cephalosporin market. Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi, and parasites, and can spread from person to person. Cephalosporin antibiotics are widely used to treat bacterial infections. According to the Centers for Disease Control and Prevention in March 2023, 8,300 tuberculosis (TB) cases were reported in the United States in 2022, up from 7,874 in 2021. The increasing prevalence of such diseases will propel the growth of the cephalosporin market.

    What Are the Major Segments of the Cephalosporin Market?

    1) By Type: Branded, Generic

    2) By Route Of Administration: Injection, Oral

    3) By Application: Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, Other Applications

    What New Trends Are Transforming the Cephalosporin Market?

    Companies in the cephalosporin market are focused on developing advanced-generation cephalosporins to address antibiotic resistance and broaden their portfolio’s effectiveness in treating various bacterial infections. Ceftobiprole, a broad-spectrum cephalosporin, is used to treat infections like skin and soft tissue infections and pneumonia. In July 2022, Mast Group Ltd., a UK-based manufacturer, launched Ceftobiprole 5µg as part of its MASTDISCS Antimicrobial Susceptibility Test range. Approved in several European countries, Ceftobiprole is effective against methicillin-resistant Staphylococcus aureus (MRSA) and has a favorable safety profile.

    Order Now for Fast Delivery of Your Cephalosporin Market Report!

    https://www.thebusinessresearchcompany.com/report/cephalosporin-global-market-report

    Which Regions Are Driving Growth in the Cephalosporin Market?

    Asia-Pacific was the largest region in the cephalosporin market in 2023. The regions covered in the cephalosporin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Cephalosporin Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cephalosporin market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Cephalosporin Market Include

    1. Cephalosporin Market Executive Summary

    2. Cephalosporin Market Segments

    3. Cephalosporin Market Size And Template Market Growth Rate

    4. Key Cephalosporin Market Trends

    5. Major Cephalosporin Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Cephalosporin Market

    26. Top Cephalosporin Companies

    27. Cephalosporin Market Opportunities And Strategies

    28. Cephalosporin Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Anti-Inflammatory Therapeutics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

    Narcotic Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

    Focal Segmental Glomerulosclerosis Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/focal-segmental-glomerulosclerosis-drugs-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Cephalosporin Market 2024

    5 Key Insights On The Cephalosporin Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Cephalosporin Global Market Report 2024, the cephalosporin market is expected to show significant growth in the forecast period.

    The cephalosporin market has shown consistent growth in recent years, driven by various factors such as the increasing prevalence of bacterial infections, antibiotic resistance, and the rising number of surgical procedures. This blog delves into the factors contributing to this growth, the forecast for the coming years, and key industry trends.

    Current Market Size and Growth

    • Market Size 2023: $17.04 billion
    • Expected Market Size 2024: $17.69 billion
    • CAGR (2023-2024): 3.8%

    The cephalosporin market has experienced steady growth due to several critical factors:

    • Growing Prevalence of Bacterial Infections: Increasing incidences of infections that require antibiotic treatment.
    • Antibiotic Resistance: Rising antibiotic resistance necessitates the development of more effective cephalosporin antibiotics.
    • Surgical Procedures and Hospitalizations: More surgeries and hospital stays increase the demand for antibiotics to prevent and treat infections.
    • Awareness and Regulatory Support: Increased awareness among healthcare professionals and supportive regulations for antibiotic development boost market growth.

    Forecast for the Cephalosporin Market

    • Market Size 2028: $20.29 billion
    • CAGR (2024-2028): 3.5%

    View More On The Cephalosporin Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cephalosporin-global-market-report

    The forecasted growth is attributed to:

    • Global Burden of Infectious Diseases: A continued increase in infectious diseases worldwide.
    • Bacterial Resistance: Ongoing challenges with emerging bacterial resistance.
    • Surgical Interventions: Continued growth in surgical procedures and healthcare-associated infections.
    • Broad-Spectrum Antibiotics Demand: Increased need for antibiotics effective against a wide range of bacteria.
    • Reimbursement Policies: Evolving reimbursement policies influencing market dynamics.

    Key Market Trends

    Technological Advancements and New Therapies

    • Advanced-Generation Cephalosporins: Companies are focusing on developing advanced-generation cephalosporins to tackle antibiotic resistance.
    • Ceftobiprole: A broad-spectrum cephalosporin used for treating various infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
      • Example: In July 2022, Mast Group Ltd. launched Ceftobiprole 5µg for antimicrobial susceptibility testing.

    Strategic Acquisitions

    • Sandoz International’s Acquisition: In October 2021, Sandoz International GmbH acquired GlaxoSmithKline PLC’s cephalosporin antibiotic business.
      • Impact: The acquisition included established brands like Zinnat, Zinacef, and Fortum, enhancing Sandoz’s antibiotic portfolio.

    Factors Driving Market Growth

    Rising Prevalence of Infectious Diseases

    • Infectious Diseases: Illnesses caused by bacteria, viruses, fungi, and parasites.
    • Impact: Increased prevalence drives demand for cephalosporin antibiotics.
      • Example: According to the CDC, TB cases in the US rose from 7,874 in 2021 to 8,300 in 2022.

    Advanced-Generation Therapies

    • Development of New Products: Companies are enhancing their portfolios with effective therapies against a broader spectrum of infections.
    • Key Product: Ceftobiprole, a 5th-generation cephalosporin, is effective against MRSA and used for pneumonia treatment.

    Market Segmentation

    The cephalosporin market is segmented by:

    1. Type: Branded, Generic
    2. Route of Administration: Injection, Oral
    3. Application: Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, Other Applications

    Regional Insights

    • Asia-Pacific: The largest region in the cephalosporin market in 2023.

    Conclusion

    The cephalosporin market continues to grow steadily, driven by the rising prevalence of infectious diseases, antibiotic resistance, and technological advancements. With strategic acquisitions and the development of advanced-generation therapies, the market is well-positioned for continued growth in the coming years.

    Request A Sample Of The Global Cephalosporin Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13402&type=smp